More than two-thirds of the 15 million coronavirus vaccines shipped within the United States have gone unused, U.S. health officials said on Jan. 4, as the governors of New York and Florida vowed to penalize hospitals that fail to dispense shots quickly.
The United States shattered the country’s daily record for coronavirus infections on Thursday, reporting more than 77,000 new cases as the number of deaths in a 24-hour period rose by nearly 1,000, according to a Reuters tally.
The U.S. Food and Drug Administration issued guidelines for where the regulatory agency will set the bar for approval of a vaccine for COVID-19.
In the battle against COVID-19, the United States continues to see spikes in multiple states, and the nation’s top virus expert says the next few weeks will be critical to contain the spread of the disease that has caused the death of more than 121,000 Americans.
Another wave of states prepared to ease coronavirus restrictions on U.S. commerce this week, despite health experts warning there is still too little diagnostic testing, while the White House forecast a staggering jump in the nation’s monthly jobless rate.
Merck & Co. Inc., Pfizer Inc., and Eli Lilly and Company announced medical service volunteer programs to enable employees who are licensed medical professionals to aid in the fight against COVID-19 while maintaining their base pay.
Forcing patients off opioid painkillers could sometimes do more harm than good, international medical experts warn in an open letter to health authorities.
More than 130,000 people were newly diagnosed with HIV last year in Eastern Europe – the highest rate ever for the region – while the number of new cases in Western Europe declined, global public health experts said.
People who have trouble falling asleep and staying asleep may want to seek advice from a doctor and avoid long-term use of sleeping pills, medical experts advise.
April 8, 2016By Alex Keown, BioSpace.com Breaking News Staff PALO ALTO, Calif. – Embattled blood-testing company Theranos is making some moves to counter criticism lobbed at the company’s leadership and the efficacy of its testing by adding more medical experts to its advisory board and opening proprietary data to scientific reviewers. Theranos has been […]